Fuji, Shigeo http://orcid.org/0000-0001-5118-7950
Yamaguchi, Takuhiro
Inoue, Yoshitaka
Utsunomiya, Atae
Moriuchi, Yukiyoshi
Owatari, Satsuki
Miyagi, Takashi
Sawayama, Yasushi
Otsuka, Eiichi
Yoshida, Shin-ichiro
Fukuda, Takahiro
Article History
Received: 14 October 2018
Revised: 25 December 2018
Accepted: 4 January 2019
First Online: 21 January 2019
Compliance with ethical standards
:
: S.F. received honoraria from the Kyowa Hakko Kirin Co., Ltd.; T.Y. had ownership interests of Statcom Co., Ltd., received consulting fees from Ono Pharmaceutical Co., Ltd., honoraria from Taiho Pharmaceutical Co., Ltd., and research funding from Kyowa Hakko Kirin Co., Ltd.; and A.U. received honoraria from Kyowa Hakko Kirin, Daiichi Sankyo, Siemens, Bristol-Myers Squibb, Pfizer, Novartis Pharma, Nippon Shinyaku, Mundi Pharma, Chugai Pharma, Ono Pharmaceutical CO, Eisai, Celgene, JIMRO, and Otsuka Pharmaceutical.